References in this report (the "Quarterly Report") to "we," "us" or the "Company" refer to Schultze Special Purpose Acquisition Corp. References to our "management" or our "management team" refer to our officers and directors, and references to the "Sponsor" refer to Schultze Special Purpose Acquisition Sponsor, LLC. The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding the Company's financial position, the business strategy, plans and objectives of management for future operations, and the impact of the coronavirus (COVID-19) pandemic on the Company's search for a Business Combination (as defined below), including the Company's ability to consummate the Clever Leaves Business Combination (as defined below), are forward-looking statements. Words such as "expect," "believe," "anticipate," "intend," "estimate," "seek" and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management's current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to Part II, Item 1A of this Quarterly Report and the Risk Factors section of the Company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on March 10, 2020. The Company's securities filings can be accessed on the EDGAR section of the SEC's website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.





Overview


We are a blank check company incorporated in Delaware on June 11, 2018 formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses ("Business Combination").

Our efforts to identify a prospective target business are not limited to a particular industry or geographic region. Although we have initially focused on businesses that have experienced and emerged from a financial restructuring, we may decide to enter into an initial Business Combination with a target business that has not experienced a financial restructuring. We intend to effectuate our initial Business Combination using cash from the proceeds of our initial public offering ("Initial Public Offering") and the sale of the private placement warrants ("Private Placement Warrants") that occurred simultaneously with the completion of our Initial Public Offering (the "Private Placement"), our securities, debt or a combination of cash, securities and debt.

The issuance of additional shares of common stock or preferred stock in a Business Combination:





  ? may significantly reduce the equity interest of our stockholders;
  ? may subordinate the rights of holders of shares of common stock if we issue
    shares of preferred stock with rights senior to those afforded to our shares
    of common stock;
  ? will likely cause a change in control if a substantial number of our shares of
    common stock are issued, which may affect, among other things, our ability to
    use our net operating loss carry forwards, if any, and most likely will also
    result in the resignation or removal of our present officers and directors;
    and
  ? may adversely affect prevailing market prices for our securities.



Similarly, if we issue debt securities or otherwise incur significant indebtedness, it could result in:





  ? default and foreclosure on our assets if our operating revenues after a
    Business Combination are insufficient to pay our debt obligations;
  ? acceleration of our obligations to repay the indebtedness even if we have made
    all principal and interest payments when due if the debt security contains
    covenants that required the maintenance of certain financial ratios or
    reserves and we breach any such covenant without a waiver or renegotiation of
    that covenant;
  ? our immediate payment of all principal and accrued interest, if any, if the
    debt security is payable on demand; and
  ? our inability to obtain additional financing, if necessary, if the debt
    security contains covenants restricting our ability to obtain additional
    financing while such security is outstanding.




                                       14




We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.





Recent Developments



Extension Meetings


On June 9, 2020, at a special meeting in lieu of the 2020 annual meeting of stockholders, our stockholders approved, among other matters, an amendment to our amended and restated certificate of incorporation to extend the date by which we had to consummate a Business Combination from June 13, 2020 to September 30, 2020 (the "First Extension"). In connection with the vote to approve the First Extension, 34,868 shares of our common stock were redeemed. As a result, an aggregate of $356,341 (or approximately $10.22 per share) was released from the trust account (the "Trust Account") to pay such redeeming stockholders.

Subsequently, on September 30, 2020, at a special meeting of stockholders, our stockholders approved an amendment to our amended and restated certificate of incorporation to extend the date by which we have to consummate a Business Combination for an additional three months, from September 30, 2020 to December 31, 2020 (the "Second Extension"). In connection with the vote to approve the Second Extension, 4,473,579 shares of our common stock were redeemed. As a result, an aggregate of $45,690,268 (or approximately $10.21 per share) was released from the Trust Account on October 2, 2020 to pay such redeeming stockholders, and 11,741,553 shares of our common stock are now issued and outstanding.





Proposed Business Combination



On July 25, 2020, we entered into a Business Combination Agreement (the "Original Agreement") with Clever Leaves International Inc., a corporation organized under the laws of British Columbia, Canada ("Clever Leaves"), Clever Leaves Holdings Inc., a corporation organized under the laws of British Columbia, Canada and a wholly-owned subsidiary of Clever Leaves ("Holdco"), and Novel Merger Sub Inc., a Delaware corporation ("Merger Sub") and a direct wholly-owned subsidiary of Holdco.

On November 9, 2020, the parties to the Original Agreement entered into an Amended and Restated Business Combination Agreement (the "Business Combination Agreement"), pursuant to which we agreed to combine with Clever Leaves in a Business Combination (the "Clever Leaves Business Combination") that will result in both Clever Leaves and the Company becoming wholly-owned subsidiaries of Holdco. Each of Holdco and Merger Sub were formed as new entities for the sole purpose of entering into and consummating the transactions set forth in the Business Combination Agreement.

Clever Leaves' mission is to be an industry-leading global cannabinoid company recognized for its principles, people and performance while fostering a healthier global community. Clever Leaves is a multi-national operator in the botanical cannabinoid and nutraceutical industries, with operations and investments in Colombia, Portugal, Germany, the United States and Canada. Clever Leaves is working to develop one of the industry's leading, low-cost global business-to-business supply chains with the goal of providing high quality pharmaceutical grade and wellness products to customers and patients at competitive prices. Clever Leaves has invested in ecologically sustainable, large-scale, botanical cultivation and processing as the cornerstone of its medical cannabinoid business, and continues to develop strategic distribution channels and brands. Clever Leaves currently owns over 1.9 million square feet of greenhouse cultivation capacity across two continents and approximately 13 million square feet of agricultural land, with an option to acquire approximately 73 million additional square feet of land for cultivation expansion. In July 2020, Clever Leaves became one of a small group of cannabis companies in the world to receive European Union Good Manufacturing Practices (EU GMP) certification.

The Business Combination Agreement and each of the other transaction documents discussed below are in each case described in more detail in the registration statement on Form S-4 (File No. 333-241707) filed by Holdco in connection with the Clever Leaves Business Combination (the "Holdco Registration Statement").





                                       15




Business Combination Agreement

Pursuant to the Business Combination Agreement, each of the following transactions will occur in the following order: (i) pursuant to a court-approved Canadian plan of arrangement (the "Plan of Arrangement", and the arrangement pursuant to such Plan of Arrangement, the "Arrangement") at the effective time of the Arrangement, based on Arrangement Consideration (as defined in the Business Combination Agreement) derived from $183,600,000: (a) all of the Clever Leaves shareholders will exchange their Clever Leaves common shares for Holdco common shares and/or non-voting Holdco common shares (as determined in accordance with the Business Combination Agreement) and (b) certain Clever Leaves shareholders will receive up to $2,000,000 in cash in the aggregate (with such amount increasing to (x) $3,000,000, if after giving effect to the exercise of certain redemption rights and payments related thereto, the funds in the Trust Account plus the proceeds from the Agreed PIPE (as defined and described below) are greater than or equal to $60,000,000 and (y) $4,000,000, if after giving effect to the exercise of redemption rights and payments related thereto, the funds in the Trust Account plus the proceeds from the Agreed PIPE are greater than or equal to $90,000,000), such that, immediately following the Arrangement, Clever Leaves will be a direct wholly-owned subsidiary of Holdco; (ii) on the calendar day immediately following the consummation of the Arrangement (the "Merger Effective Time" and the date on which the Merger Effective Time occurs, the "Closing Date"), Merger Sub will merge with and into the Company, with the Company surviving such merger as a direct wholly-owned subsidiary of Holdco (the "Merger") and, as a result of the Merger, all of the shares of our common stock will be converted into the right to receive Holdco common shares as set forth in the Business Combination Agreement; (iii) immediately following the consummation of the Merger, Holdco will contribute 100% of the issued and outstanding capital stock of the Company (as the surviving corporation of the Merger) to Clever Leaves, such that, the Company will be a direct wholly-owned subsidiary of Clever Leaves; and (iv) immediately following the contribution of the Company to Clever Leaves, Clever Leaves will contribute 100% of the issued and outstanding shares of NS US Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of Clever Leaves, to the Company.

The consummation of the Clever Leaves Business Combination is subject to a number of conditions set forth in the Business Combination Agreement including, among others, receipt of the requisite approval of our stockholders, our having at least $26,000,000 available either in or outside the Trust Account and the execution of the various transaction agreements.

Shareholder Support Agreements

In connection with the execution of the Original Agreement, we entered into Shareholder Support Agreements with Holdco and certain Clever Leaves shareholders ("Key Clever Leaves Shareholders"), pursuant to which among other things, the Key Clever Leaves Shareholders agreed to vote their Clever Leaves shares in favor of the Business Combination Agreement, the Plan of Arrangement, the Arrangement, resolutions of Clever Leaves to approve the Plan of Arrangement and the Arrangement, the Clever Leaves Business Combination and certain related transactions. The Key Clever Leaves Shareholders include all Clever Leaves shareholders that are executive officers, directors, affiliates, founders and their family members, and certain holders of 5% or more of the outstanding voting Clever Leaves shares. Additionally, the Key Clever Leaves Shareholders are subject to a restriction on sales and transfers of their Holdco common shares commencing on the effective date of the Holdco Registration Statement (the "Effective Date") and ending one year following the Closing Date, with such restriction on sales and transfers to terminate early if following the 180th day after the Closing Date, the closing trading price of the Holdco common shares equals or is greater than $12.50 for any 20 out of any 30 consecutive trading days.





Transaction Support Agreement



Concurrently with the execution of the Original Agreement, we entered into the Transaction Support Agreement, as amended on November 9, 2020 (the "Transaction Support Agreement"), with our Sponsor, Clever Leaves and Holdco, pursuant to which, among other things:

(i) we and our Sponsor agreed to take all actions necessary, at or prior to the


     closing of the Clever Leaves Business Combination (the "Closing"), to amend
     the Stock Escrow Agreement, dated as of December 10, 2018 (the "Stock Escrow
     Agreement"), by and among our Sponsor, certain of our stockholders named
     therein, Continental Stock Transfer & Trust Company ("Continental"), as
     escrow agent ("Escrow Agent"), and us, pursuant to which the Founder Shares
     (as defined below) are held in escrow, and we and our Sponsor agreed to use
     reasonable best efforts to cause Continental and the other parties to the
     Stock Escrow Agreement to establish, pursuant to an amendment to the Stock
     Escrow Agreement to be entered into by our Sponsor, other initial
     stockholders party thereto, the Escrow Agent and us in connection with the
     Clever Leaves Business Combination, the escrow terms of certain Holdco common
     shares to be held by our Sponsor and our current independent directors
     following the Clever Leaves Business Combination;



(ii) our Sponsor agreed, subject to and conditioned upon the occurrence of the


      Closing and effective as of immediately prior to the Merger Effective Time,
      to forfeit for no consideration all warrants in its possession other than
      (a) (A) a number of Holdco warrants (rounded down to the nearest whole
      warrant) equal to (B) 1,245,000 plus (C) the quantity of (1) 2,905,000
      multiplied by (2) the quotient obtained by dividing (I) the quantity of (x)
      the aggregate amount of cash held either in or outside the Trust Account,
      including the aggregate amount from the PIPEs (including for the avoidance
      of doubt, the aggregate amount of the Agreed PIPE), after giving effect to
      the exercise of redemption rights and payments related thereto minus (y)
      $25,000,000 by (II) $20,000,000 (the "Sponsor Warrant Amount") (provided
      that in no event shall the Sponsor Warrant Amount be less than 1,245,000
      warrants or greater than 4,150,000 warrants) and (b) the Working Capital
      Warrants (as defined in the Warrant Amendment described below), if any,
      issued to our Sponsor in full satisfaction of loans made by our Sponsor to
      us pursuant to a promissory note or notes; and




                                       16




(iii) certain service providers of Holdco and its subsidiaries at the direction


       of the Holdco board of directors or any committee thereof (the "Earnout
       Shareholders") are eligible to receive up to 1,440,000 Holdco common
       shares, in the form of an earnout, and such Holdco common shares will be
       issued to the Earnout Shareholders under the 2020 Earnout Award Plan of
       Holdco as follows: (A) 720,000 Holdco common shares will be issued to the
       Earnout Shareholders only if the closing price of the Holdco common shares
       on the Nasdaq Capital Market equals or exceeds $12.50 per share (as
       adjusted for stock splits, reverse splits, stock dividends,
       reorganizations, recapitalizations or any similar event) for any 20 trading
       days within any consecutive 30 trading day period on or before the second
       anniversary of the Closing; and (B) 720,000 Holdco common shares will be
       issued to the Earnout Shareholders only if the closing price of the Holdco
       common shares on Nasdaq equals or exceeds $15.00 per share (as adjusted for
       stock splits, reverse splits, stock dividends, reorganizations,
       recapitalizations or any similar event) for any 20 trading days within any
       consecutive 30 trading day period on or before the fourth anniversary of
       the Closing. The Holdco board of directors intends to delegate its
       authority to select the Earnout Shareholders to a committee comprised of
       Kyle Detwiler and Andres Fajardo and, in consultation with such committee,
       may impose additional vesting conditions on the vesting of such shares. The
       Holdco common shares held by our Sponsor and our current independent
       directors will be released from escrow to our Sponsor and our current
       independent directors as follows: (1) the Sponsor Upfront Escrow Shares
       will be released to our Sponsor (and 60,000 of such Sponsor Upfront Escrow
       Shares will be released to our current independent directors) at the
       earlier of: (x) one year following the Closing or (y) the date on which the
       closing price of the Holdco common shares on Nasdaq equals or exceeds
       $12.50 per share (as adjusted for stock splits, stock dividends,
       reorganizations, and recapitalizations) for any 20 trading days within any
       consecutive 30 trading day period after the Closing; (2) fifty percent
       (50%) of the Sponsor Earn-Out Shares will be released to our Sponsor if the
       closing price of the Holdco common shares on Nasdaq equals or exceeds
       $12.50 per share (as adjusted for stock splits, stock dividends,
       reorganizations, and recapitalizations) for any 20 trading days within any
       consecutive 30 trading day period on or before the second anniversary of
       the Closing; and (3) the other fifty percent (50%) of the Sponsor Earn-Out
       Shares will be released to our Sponsor if the closing price of the Holdco
       common shares on Nasdaq equals or exceeds $15.00 per share (as adjusted for
       stock splits, stock dividends, reorganizations, and recapitalizations) for
       any 20 trading days within any consecutive 30 trading day period on or
       before the fourth anniversary of the Closing. Additionally, our Sponsor is
       subject to a restriction on sales and transfers of its Holdco common shares
       commencing on the Effective Date, and ending one year following the Closing
       Date, with such restriction on sales and transfers to terminate early if
       following the 180th day after the Closing Date, the closing trading price
       of the Holdco common shares equals or is greater than $12.50 for any 20 out
       of any 30 consecutive trading days. For purposes of the preceding sentence,
       (1) the "Sponsor Upfront Escrow Shares" means a number of Holdco common
       shares (rounded down to the nearest whole share) equal to (x) (i) an
       aggregate amount equal to (A) the aggregate amount of cash held either in
       or outside the Trust Account, including the aggregate amount of PIPEs,
       including, for the avoidance of doubt, the aggregate amount of the Agreed
       PIPE (excluding the accrued and outstanding interest under the $27,750,000
       aggregate principal amount of secured convertible notes of Clever Leaves
       due March 30, 2022 (the "Secured Convertible Notes")) consummated prior to,
       or as of, the Closing, after giving effect to the exercise of redemption
       rights and payments related thereto minus (B) our good faith estimate of
       our transaction expenses multiplied by (ii) twenty percent (20%) (such
       amount in this subsection (x), the "Sponsor Value") divided by (y) $10.00;
       provided that the number of Sponsor Upfront Escrow Shares shall not be less
       than 460,000 Holdco common shares or more than 1,168,421 Holdco common
       shares; and (2) the "Sponsor Earn-Out Shares" means a number of Holdco
       common shares (rounded down to the nearest whole share) equal to (x) an
       amount equal to (i) the Sponsor Value minus (ii) (A) the Sponsor Upfront
       Escrow Shares multiplied by (B) $10.00, divided by (y) $5.00; provided,
       that the number of Sponsor Earn-Out Shares shall not be less than 0 or
       greater than 1,300,000.



Investors' Rights Agreement

In connection with, and as a condition to the consummation of, the Clever Leaves Business Combination, at the Closing, Holdco and certain of our stockholders will enter into an Investors' Rights Agreement (the "Investors' Rights Agreement"), pursuant to which, among other things:

? so long as the Minimum Holding Condition is satisfied, the holders of a

majority of the Holdco common shares party to the Investors' Rights Agreement

(the "Majority Holders") will have the right to nominate one director to the


   Holdco board of directors;



? if (A) at the time of the Closing, the size of the Holdco board of directors is

composed of five or fewer directors, (B) Holdco proposes for the number of

directors comprising the Holdco board of directors to be greater than five

directors and (C) at the time Holdco makes such proposal, the Minimum Holding

Condition is satisfied, then prior to the nomination (or, if there is no

nomination, the appointment) of a sixth individual to the Holdco board of

directors, the Majority Holders will have the right to consent (such consent

not to be unreasonably withheld, conditioned or delayed) to the nomination (or,

if there is no nomination, the appointment) of such additional director. The

right to consent to such additional director will expire upon an additional

director becoming a member of the Holdco board of directors in accordance with

the requirements of the Investors' Rights Agreement; and

? certain of our stockholders will be entitled to customary registration rights

for their respective Holdco common shares.

For purposes of the Investors' Rights Agreement, the "Minimum Holding Condition" is considered satisfied for so long as the Majority Holders hold: (i) 50% of the total number of Holdco common shares held by such holders on the date of the Investors' Rights Agreement and (ii) 2% of the then-issued and outstanding Holdco common shares, as determined on a fully diluted basis, including any earn-out shares for so long as the earn-out remains capable of being satisfied; provided that if the holdings of our Sponsor and our other stockholders that are party to the Investors' Rights Agreement do not satisfy the foregoing clause (ii) at the Closing, the Minimum Holding Condition shall nevertheless be deemed satisfied until such time that such shareholders sell any Holdco common shares at which time the Minimum Holding Condition shall immediately cease to be satisfied.





                                       17





Warrant Amendment



In connection with, and as a condition to the consummation of, the Clever Leaves Business Combination, at the Closing, we will enter into an Assignment, Assumption and Amendment Agreement (the "Warrant Amendment") with Holdco and Continental, as warrant agent, pursuant to which, as of the Merger Effective Time, (a) each of our warrants that is outstanding immediately prior to the Merger Effective Time will no longer represent a right to acquire one share of our common stock and will instead represent the right to acquire one Holdco common share under the same terms as set forth in the Warrant Agreement, dated as of December 10, 2018 (the "Warrant Agreement"), between us and Continental, and (b) we will assign to Holdco all of our right, title and interest in and to such existing Warrant Agreement and Holdco will assume, and agree to pay, perform, satisfy and discharge in full, all of our liabilities and obligations under such existing Warrant Agreement arising from and after the Merger Effective Time.





Subscription Agreements



In connection with the Clever Leaves Business Combination, we have obtained commitments from interested investors (the "Subscribers") to purchase (a) shares of our common stock for a purchase price of $9.50 per share or (b) Holdco common shares or securities or indebtedness exercisable or exchangeable for, or convertible into, Holdco common shares, in each case, which will be converted into Holdco common shares in connection with the Closing (the "PIPE Shares"), in a private placement toclose immediately prior to the Closing of the Clever Leaves Business Combination (the "Agreed PIPE"). The Subscribers have committed an aggregate of $8.9 million to participate in the Clever Leaves Business Combination through the Agreed PIPE, of which $6.0 million is to be paid in cash and $2.9 million is to be paid via the cancellation of accrued and outstanding interest on the Secured Convertible Notes. Such commitments are being made by way of the subscription agreements, by and among each Subscriber, Holdco and us (the "Subscription Agreements"). The purpose of the Agreed PIPE is to raise additional capital for use in connection with the Clever Leaves Business Combination and to meet the minimum cash requirements provided in the Business Combination Agreement. The Subscription Agreements were entered into on November 9, 2020.

The closing of the Agreed PIPE (the "PIPE Closing") is contingent upon the substantially concurrent consummation of the Clever Leaves Business Combination. The PIPE Closing will occur on the date of, and immediately prior to, the consummation of the Clever Leaves Business Combination. The PIPE Closing will be subject to customary closing conditions.

Pursuant to the Subscription Agreements, Holdco agreed that, if the Holdco common shares issuable to the Subscribers in exchange for their PIPE Shares are not registered in connection with the Clever Leaves Business Combination, within 30 calendar days after the Closing, Holdco will file with the SEC (at Holdco's sole cost and expense) a registration statement registering the resale of the PIPE Shares received by the Subscribers in connection with the Clever Leaves Business Combination (the "Resale Registration Statement"), and Holdco shall use its commercially reasonable efforts to have the Resale Registration Statement declared effective no later than 90 days (or 45 days if the SEC notifies Holdco that it will not review the Resale Registration Statement) after the Closing; provided, however, that Holdco's obligations to include the PIPE Shares held by a Subscriber in the Resale Registration Statement will be contingent upon the respective Subscriber furnishing in writing, to Holdco, such information regarding the Subscriber, the securities of Holdco held by such Subscriber and the intended method of disposition of the shares, as shall be reasonably requested by Holdco to effect the registration of such shares, and will execute such documents in connection with such registration, as Holdco may reasonably request, which will be what is customary of a selling stockholder in similar situations.

Holdco will also be required to use its commercially reasonable efforts to cause the Resale Registration Statement to become effective and to maintain the effectiveness of the Resale Registration Statement until the earliest of (a) the date on which all of the PIPE Shares may be sold without restriction under Rule 144, (b) the date on which the Subscribers cease to hold any PIPE Shares acquired pursuant to the Clever Leaves Business Combination, and (c) the second anniversary of the Closing; provided that the period under this clause (c) may be extended by the same number of days that the Resale Registration Statement is entitled to be suspended under the Subscription Agreements.

Holdco is entitled to delay, postpone or suspend the effectiveness of the Resale Registration Statement if an event has occurred that the Holdco board of directors reasonably believes would require additional disclosure by Holdco in the Resale Registration Statement of material non-public information. However, Holdco may not delay or suspend the Resale Registration Statement on more than two occasions in any 12-month period or for more than 60 consecutive days, or more than 90 total days, in each case during any 12-month period.

Each Subscription Agreement will terminate upon the earlier to occur of (w) such date and time as the Business Combination Agreement is terminated in accordance with its terms, (x) upon the mutual written agreement of each of the parties to the Subscription Agreement, (y) any of the conditions to the PIPE Closing are not satisfied or waived on or prior to the PIPE Closing and, as a result thereof, the transactions contemplated by the Subscription Agreement are not consummated at the PIPE Closing or (z) December 31, 2020.

Holdco Registration Statement

In connection with the Clever Leaves Business Combination, on August 6, 2020, Holdco filed the Holdco Registration Statement with the SEC, which includes a preliminary proxy statement with respect to our special meeting of stockholders to approve the Business Combination Agreement, among other matters, that constitutes a preliminary prospectus of Holdco. On September 14, 2020, Holdco filed Amendment No. 1 to the Holdco Registration Statement with the SEC.





                                       18




Effects of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic has resulted in a widespread health crisis that has adversely affected the economies and financial markets worldwide. While we believe we many have experienced delays communicating with and conducting due diligence with regard to certain potential target companies because of reduced availability of personnel of such companies, we do not believe the COVID-19 has had a significant impact on our ability to identify and conduct due diligence with respect to prospective target companies. The extent to which the COVID-19 pandemic may impact our ability to consummate a Business Combination, including the Clever Leaves Business Combination, will depend on future developments which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others.

Various governmental bodies and private enterprises have implemented preventative or protective measures to contain the COVID-19 pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns, and these actions may continue to expand in scope, type and impact. These measures, in addition to the disruption of economies and financial markets worldwide caused by the COVID-19 pandemic, could result in direct and indirect adverse effects on the industries in which Clever Leaves operates. The extent to which the COVID-19 pandemic may impact Clever Leaves' operations and our ability to consummate the Clever Leaves Business Combination is uncertain.





Results of Operations


We have neither engaged in any operations nor generated any revenues to date. Our only activities from June 11, 2018 (inception) to September 30, 2020 were organizational activities, those necessary to prepare for our Initial Public Offering, described below, identifying a target company for a Business Combination and the Clever Leaves Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We generate non-operating income in the form of interest income on marketable securities held after our Initial Public Offering. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination. We are also incurring expenses in connection with the Clever Leaves Business Combination.

For the three months ended September 30, 2020, we had net loss of $255,684, which consisted of operating costs of $334,472, offset by interest income on marketable securities held in the Trust Account of $34,297 and a benefit for income taxes of $44,491. The increase in operating expense is mainly attributable to costs incurred in connection with the Second Extension. The decrease in interest income is mainly attributable to the lower interest rates earned during the three months ended September 30, 2020, as compared to prior periods.

For the nine months ended September 30, 2020, we had net loss of $175,298, which consisted of operating costs of $863,340, offset by interest income on marketable securities held in the Trust Account of $664,920 and a benefit for income taxes of $23,122. The increase in operating expense is mainly attributable to costs incurred in connection with the First and Second Extensions. The decrease in interest income is mainly attributable to the lower interest rates earned during the three and nine months ended September 30, 2020, as compared to prior periods.

For the three months ended September 30, 2019, we had a net income of $459,977, which consisted of interest income on marketable securities held in the Trust Account of $732,727 and an unrealized gain on marketable securities held in the Trust Account of $15,376, offset by operating costs of $135,101 and a provision for income taxes of $122,273.

For the nine months ended September 30, 2019, we had a net income of $1,510,593, which consisted of interest income on marketable securities held in the Trust Account of $2,309,144 and an unrealized gain on marketable securities held in the Trust Account of $29,539, offset by operating costs of $426,540 and a provision for income taxes of $401,550.

Liquidity and Capital Resources

Until the consummation of our Initial Public Offering, our only source of liquidity was receipt of $25,000 from an initial purchase of common stock by our Sponsor ("Founder Shares") and $200,000 in loans from our Sponsor pursuant to the terms of a promissory note. We fully repaid the loans from our Sponsor on December 13, 2018.

On December 13, 2018, we consummated our Initial Public Offering of 13,000,000 units ("Units") at $10.00 per Unit, generating gross proceeds of $130,000,000. Simultaneously with the closing of our Initial Public Offering, we consummated the sale of 4,150,000 Private Placement Warrants to our Sponsor at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $4,150,000.

Immediately following the closing of our Initial Public Offering, a total of $130,000,000 ($10.00 per Unit) of the net proceeds from our Initial Public Offering and the Private Placement was placed in the Trust Account. Transaction costs amounted to $3,158,259, consisting of $2,600,000 of underwriting fees, and $558,259 of other costs.

For the nine months ended September 30, 2020, cash used in operating activities was $693,943. Net loss of $175,298 was offset by interest earned on marketable securities held in the Trust Account of $664,920 and a deferred tax benefit of $23,122. Changes in operating assets and liabilities provided $169,397 of cash from operating activities.





                                       19




For the nine months ended September 30, 2019, cash used in operating activities was $430,149. Net income of $1,510,593 was offset by interest earned on marketable securities held in the Trust Account of $2,309,144, an unrealized gain on marketable securities held in the Trust Account of $29,539 and a deferred tax provision of $6,203. Changes in operating assets and liabilities provided $391,738 of cash from operating activities.

As of September 30, 2020, we had marketable securities held in the Trust Account of $132,467,547. Interest income on the Trust Account will be used by us to pay franchise and income taxes. For the nine months ended September 30, 2020, we withdrew $230,612 of interest earned on the Trust Account to pay franchise and income taxes. We intend to use substantially all of the funds held in the Trust Account to acquire a target business and to pay our expenses relating thereto, including a fee of $4,550,000 payable to EarlyBirdCapital, Inc. (exclusive of any applicable finders' fees which might become payable, and subject to our right to allocate up to 35% of the fee to any of the underwriters in our Initial Public Offering or other FINRA member firms we retain to assist us in connection with our initial Business Combination) upon consummation of our initial Business Combination for assisting us in connection with our initial Business Combination pursuant to a business combination marketing agreement. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account, after payment for properly redeemed public shares, as well as any other net proceeds not expended will be used as working capital to finance the operation of the target business or businesses, make other acquisitions and pursue our growth strategies.

At September 30, 2020, we had cash of $134,043 held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses, review corporate documents and material agreements of prospective target businesses, select the target business to acquire and structure, negotiate and consummate a Business Combination.

Other than as described below, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our initial Business Combination, without interest, or, at the holder's discretion, up to $1,500,000 of the notes may be converted into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. If we do not complete a Business Combination, the loans will be forgiven. As of September 30, 2020, we had no promissory notes outstanding.

On July 29, 2020, as amended on October 26, 2020, our Sponsor committed to provide us an aggregate of $500,000 in loans in order to finance transaction costs in connection with a Business Combination. To the extent advanced, the loans will be evidenced by a promissory note, will be non-interest bearing, unsecured and will only be repaid upon the completion of a Business Combination. The loans may also be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. To date, no amounts have been borrowed under the commitment.

Based on the foregoing, management believes we will have sufficient cash to meet our needs through the earlier of consummation of a Business Combination or December 31, 2020, the date we will be required to cease all operations except for the purpose of winding up, if a Business Combination is not consummated. We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to consummate our initial Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial Business Combination. Following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Off-Balance Sheet Arrangements

As of September 30, 2020, we have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.





                                       20





Contractual Obligations


We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities other than a monthly fee of up to an aggregate of $10,000 payable to our Sponsor for general and administrative services, including office space, utilities and administrative support. We began incurring these fees on December 10, 2018 and will continue to incur these fees until the earlier of the completion of our initial Business Combination or our liquidation.

We engaged EarlyBirdCapital, Inc. as advisor in connection with our Business Combination to assist us in holding meetings with our stockholders to discuss the potential Business Combination and the target business' attributes, introduce us to potential investors that are interested in purchasing our securities in connection with the potential Business Combination, assist us in obtaining stockholder approval for the Business Combination and assist us with our press releases and public filings in connection with the Business Combination. We will pay EarlyBirdCapital, Inc. a cash fee for such services upon the consummation of an initial Business Combination in an amount equal to $4,550,000; provided that we have the right to allocate up to 35% of the fee to any of the underwriters in the Initial Public Offering or other FINRA member firms we retain to assist us in connection with our initial Business Combination. On May 27, 2020, we engaged Canaccord Genuity LLC to provide financial advisory services, which may include acting as a placement agent in connection with a PIPE, if any, in connection with the Clever Leaves Business Combination. We intend to use at least a portion of this allocation to pay Canaccord Genuity.

Critical Accounting Policies

Management's discussion and analysis of our results of operations and liquidity and capital resources are based on our financial information. The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification Topic 480 "Distinguishing Liabilities from Equity." Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders' equity section of our condensed balance sheets.





Net Loss Per Common Share


We apply the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. Our net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not our income or losses.





Recent Accounting Standards


Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

© Edgar Online, source Glimpses